ClinicalTrials.govpublic full text
A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative disorders, chronic myelomonocytic leukemia, lintuzumab, antigens, cd33, antibodies, monoclonal, leukemia, myeloid, acute, myelodysplastic syndromes, hematologic diseases, leukemia, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880780
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.